Concomitant suppression of S1P and enhancement of intracellular C16 Cer levels by inhibition of SK1 activity may serve as an effective strategy to restore a healthy balance between pro- and anti-apoptotic signaling in metabolically dynamic pancreatic cancers. This evidence concerns the gene SPHK1 and familial pancreatic carcinoma.